Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 18;15(2):e0229218.
doi: 10.1371/journal.pone.0229218. eCollection 2020.

Validation of a hierarchical algorithm to define chronic liver disease and cirrhosis etiology in administrative healthcare data

Affiliations

Validation of a hierarchical algorithm to define chronic liver disease and cirrhosis etiology in administrative healthcare data

George Philip et al. PLoS One. .

Abstract

Background and aims: Chronic liver disease (CLD) and cirrhosis are leading causes of death globally with the burden of disease rising significantly over the past several decades. Defining the etiology of liver disease is important for understanding liver disease epidemiology, healthcare planning, and outcomes. The aim of this study was to validate a hierarchical algorithm for CLD and cirrhosis etiology in administrative healthcare data.

Methods: Consecutive patients with CLD or cirrhosis attending an outpatient hepatology clinic in Ontario, Canada from 05/01/2013-08/31/2013 underwent detailed chart abstraction. Gold standard liver disease etiology was determined by an attending hepatologist as hepatitis C (HCV), hepatitis B (HBV), alcohol-related, non-alcoholic fatty liver disease (NAFLD)/cryptogenic, autoimmune or hemochromatosis. Individual data was linked to routinely collected administrative healthcare data at ICES. Diagnostic accuracy of a hierarchical algorithm incorporating both laboratory and administrative codes to define etiology was evaluated by calculating sensitivity, specificity, positive (PPV) and negative predictive values (NPV), and kappa's agreement.

Results: 442 individuals underwent chart abstraction (median age 53 years, 53% cirrhosis, 45% HCV, 26% NAFLD, 10% alcohol-related). In patients with cirrhosis, the algorithm had adequate sensitivity/PPV (>75%) and excellent specificity/NPV (>90%) for all etiologies. In those without cirrhosis, the algorithm was excellent for all etiologies except for hemochromatosis and autoimmune diseases.

Conclusions: A hierarchical algorithm incorporating laboratory and administrative coding can accurately define cirrhosis etiology in routinely collected healthcare data. These results should facilitate health services research in this growing patient population.

PubMed Disclaimer

Conflict of interest statement

I have read the journal’s policy and the authors of the manuscript have the following competing interests: Jennifer A. Flemming declares investigator-driven research support received from Gilead Sciences Canada, as well as speaker fees from Gilead Sciences, AbbVie, and Lupin Pharmaceuticals. The commercial affiliations of author JAF had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of author’s salaries. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1
Fig 1. Hierarchical algorithm to define CLD and cirrhosis etiology in administrative healthcare data.
HCV: hepatitis C; HBV: hepatitis B; sAg: surface antigen; AIH: autoimmune hepatitis; PBC: primary biliary cholangitis; PSC: primary sclerosing cholangitis.

Similar articles

Cited by

References

    1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The lancet. 2012. December 15;380(9859):2095–128. - PMC - PubMed
    1. Heron M. National Vital Statistics Reports Volume 65, Number 5 June 30, 2016 Deaths: Leading Causes for 2014. 2016;65(5). - PubMed
    1. Flemming JA, Dewit Y, Mah JM, Saperia J, Groome P, Booth CM. Increased Cirrhosis Incidence in Young Birth Cohorts from 1997–2016: A population-based study. 2019. Lancet Gastroenterol Hepatol. 4(3): 217–226. 10.1016/S2468-1253(18)30339-X - DOI - PubMed
    1. Tapper EB and Parikh ND. Mortality due to cirrhosis and liver cancer in the United States 1999–2016: observational study. BMJ. 2018; 18(362), epub ahead of print. - PMC - PubMed
    1. Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med. 2000;342(17):1266 10.1056/NEJM200004273421707 - DOI - PubMed

Publication types

MeSH terms

Grants and funding

JAF: American Association for the Study of Liver Disease Foundation Clinical, Translational and Outcomes Research Award in Liver Disease (http://www.aasldfoundation.org/); Southeastern Ontario Academic Medical Association New Clinician Scientist Award (https://www.seamo.ca/). The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.